Skip to main content
Premium Trial:

Request an Annual Quote

GenePOC Strep A Test Granted FDA Clearance

NEW YORK (GenomeWeb) – GenePOC announced today that its rapid molecular assay to detect group A Streptococcus has been granted clearance by the US Food and Drug Administration.

The test, which runs on GenePOC's Revogene instrument, is the third test from the Quebec City-based diagnostics developer to be FDA cleared. It uses throat swab samples and can report positive Strep A results in as little as 42 minutes, and negative results in 70 minutes without requirement for confirmation by bacterial culture, the firm said in a statement. 

The company obtained FDA clearance of its Revogene instrument and an assay for group B Strep in 2017, followed by an assay to detect Clostridium difficile. GenePOC is also currently developing small molecular panels for carbapenem-resistant enterobacteriaceae (CRE) and gastrointestinal infections.

"GenePOC is committed to developing important assays to complete its current offering, becoming a strong player in the field of rapid molecular diagnostics," CEO Patrice Allibert said.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.